Physician profile
Sherman Chen
NPI 1982808101
$1,326.83
in general payments reported to CMS, 2019-2025
11 companies · $841 in 2025
The $841 reported for 2025 was more than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.68 · 2022: $201 · 2023: $85.76 · 2024: $152 · 2025: $841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $552 · Food and Beverage: $507 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $552.06 |
| Food and Beverage | $507.26 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $844.87 | 2019-2025 | Evolve, Target, Broadway 8 |
| Medtronic, INC. | $277.07 | 2022-2025 | Pipeline, Onyx 18 |
| Chiesi USA, INC. | $49.06 | 2019-2024 | Cleviprex, Kengreal |
| Orthofix Medical, INC. | $36.13 | 2022 | |
| Sanara Medtech INC. | $27.06 | 2023 | Celleraterx |
| Depuy Synthes Sales INC. | $23.03 | 2025 | Fibergraft Aeridyan Matrix, Symphony, Fibergraft Bg Morsels |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Alexion Pharmaceuticals, INC. | $18.76 | 2022 | |
| Microvention, INC. | $16.86 | 2023 | Web Aneurysm Embolization System |
| Cordis US Corp. | $13.99 | 2025 | Mynx Control Venous |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherman Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.